Effectiveness of Paclitaxel-Eluting Balloon Catheter in Patients With Sirolimus-Eluting Stent Restenosis

References

Page 1

	Year	Citations
Clinical End Points in Coronary Stent Trials Donald E. Cutlip, Stephan Windecker, Roxana Mehran, Circulation	2007	5.4K
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, New England Journal of Medicine	2003	4.2K
Pathology of Drug-Eluting Stents in Humans Michael Joner, Aloke V. Finn, Andrew Farb, Journal of the American College of Cardiology Percutaneous Coronary InterventionVascular DiseaseCardiovascular DiseasePharmacologyVascular Surgery	2006	2.7K
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent Renu Virmani, Giulio Guagliumi, Andrew Farb, Circulation	2004	1.5K
Angiographic Patterns of In-Stent Restenosis Roxana Mehran, George Dangas, Gary S. Mintz, Circulation	1999	1.3K
Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter Bruno Scheller, Christoph Hehrlein, Wolfgang Bocksch, New England Journal of Medicine	2006	797
Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents Jonathan R. Nebeker, Renu Virmani, Charles L. Bennett, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseCardiologyMedicineAtherosclerosis	2005	607
Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial David R. Holmes, Martin B. Leon, Jeffrey W. Moses, Circulation	2004	515
Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis Martin Unverdorben, C. Vallbracht, Bodo Cremers, Circulation	2009	504
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents Adnan Kastrati, Alban Dibra, Julinda Mehilli, Circulation	2006	311

Page 1